Regenerative Medicine Market by Product (Cell Therapies (Autologous, Allogenic), Stemcell Therapy, Tissue-engineering, Gene Therapy), Application (Wound Care, Musculoskeletal, Oncology, Dental, Ocular), Geography - Global Forecast to 2025

Table of Contents

1.... INTRODUCTION

1.1             OBJECTIVES OF THE STUDY
1.2             MARKET DEFINITION
・       FIGURE 1....................................... INCLUSIONS & EXCLUSIONS
1.2.1              MARKETS COVERED.. 25
1.2.2              YEARS CONSIDERED FOR THE STUDY
1.3             CURRENCY
1.4             LIMITATIONS
1.5             STAKEHOLDERS
1.6             REPORT COMPARISON WITH THE MARCH 2019 EDITION
1.6.1              SUMMARY OF CHANGES
1.6.2              LIMITATIONS OF THE CURRENT EDITION

2.... RESEARCH METHODOLOGY

2.1             RESEARCH DATA
・       FIGURE 2.................................................. RESEARCH DESIGN.. 28
2.1.1              SECONDARY DATA
2.1.1.1            KEY DATA FROM SECONDARY SOURCES
2.1.2              PRIMARY DATA
・       FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2             MARKET SIZE ESTIMATION
2.2.1              BOTTOM-UP APPROACH
・       FIGURE 4............. REGENERATIVE MEDICINE MARKET: BOTTOM-UP APPROACH
2.2.2              TOP-DOWN APPROACH.. 32
・       FIGURE 5 REGENERATIVE MEDICINE MARKET: TOP-DOWN APPROACH
2.3             MARKET BREAKDOWN AND DATA TRIANGULATION
・       FIGURE 6.......................... DATA TRIANGULATION METHODOLOGY
2.4             ASSUMPTIONS FOR THE STUDY

3.... EXECUTIVE SUMMARY

・       FIGURE 7........... REGENERATIVE MEDICINE MARKET, BY PRODUCT,
2020 VS. 2025 (USD MILLION)
・       FIGURE 8....... REGENERATIVE MEDICINE MARKET, BY APPLICATION,
2020 VS. 2025 (USD MILLION)
・       FIGURE 9.............. REGENERATIVE MEDICINE MARKET, BY REGION,
2020 VS. 2025 (USD MILLION)

4.... PREMIUM INSIGHTS

4.1             REGENERATIVE MEDICINE MARKET OVERVIEW... 38
・       FIGURE 10.... GROWING INVESTMENTS IN REGENERATIVE MEDICINE RESEARCH TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
4.2             CELL THERAPIES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
・       FIGURE 11.......... AUTOLOGOUS CELL THERAPIES TO DOMINATE THE REGENERATIVE MEDICINE MARKET IN THE FORECAST PERIOD.. 39
4.3             REGENERATIVE MEDICINE MARKET SHARE, BY APPLICATION, 2020 VS. 2025
・       FIGURE 12.......... MUSCULOSKELETAL DISORDERS IS THE LARGEST APPLICATION SEGMENT OF THE REGENERATIVE MEDICINE MARKET. 39
4.4             REGENERATIVE MEDICINE MARKET, BY REGION, 2020−2025
・       FIGURE 13..... NORTH AMERICA TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD

5.... MARKET OVERVIEW

5.1             INTRODUCTION
5.2             MARKET DYNAMICS
・       FIGURE 14............... REGENERATIVE MEDICINE MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
5.2.1              DRIVERS
5.2.1.1            RISING PREVALENCE OF CHRONIC DISEASES, GENETIC DISORDERS, AND CANCER
・       FIGURE 15..... INCIDENCE OF DIABETES, BY REGION, 2015 VS. 2040 (MILLION CASES)
・       TABLE 1.... CANCER INCIDENCE AND MORTALITY, BY REGION, 2012–2035
・       TABLE 2. OBESITY-ASSOCIATED DEATH RATE (%), BY COUNTRY, 2017
5.2.1.2            RISING INVESTMENTS IN REGENERATIVE MEDICINE RESEARCH
・       TABLE 3......... TOTAL FUNDING, BY SOURCE TYPE, 2016–2019 (USD MILLION)
・       TABLE 4.. FUNDING FROM CORPORATE PARTNERSHIPS, 2018–2019 (USD MILLION)
・       TABLE 5........... FUNDRAISING THROUGH PUBLIC OFFERINGS (IPO & FOLLOW-ONS),
2018–2019 (USD MILLION)
・       TABLE 6. FUNDING FOR REGENERATIVE MEDICINE RESEARCH BY THE NIH UNDER
THE 21ST CENTURY CURES ACT, 2017–2019 (USD BILLION)
・       TABLE 7.......... CALIFORNIA INSTITUTE OF REGENERATIVE MEDICINE FUNDING FOR REGENERATIVE MEDICINE RESEARCH (2017)
5.2.1.3            GROWING PIPELINE OF REGENERATIVE MEDICINE PRODUCTS
・       TABLE 8 NUMBER OF COMPANIES OPERATING IN THE REGENERATIVE MEDICINE MARKET, BY REGION, 2016–2018
・       TABLE 9.......... NUMBER OF CLINICAL TRIALS IN THE REGENERATIVE MEDICINE MARKET,
BY CLINICAL PHASE, 2018 VS. 2019
・       TABLE 10....... NUMBER OF M&A TRANSACTIONS, 2016–2019 (USD MILLION)
5.2.2              RESTRAINTS
5.2.2.1            ETHICAL CONCERNS RELATED TO THE USE OF EMBRYONIC STEM CELLS IN RESEARCH & DEVELOPMENT
5.2.2.2            HIGH COST OF CELL AND GENE THERAPIES
5.2.3              OPPORTUNITIES
5.2.3.1            IMPLEMENTATION OF THE 21ST CENTURY CURES ACT
5.2.3.2            RISING DEMAND FOR ORGAN TRANSPLANTATIONS
5.3             IMPACT OF THE COVID-19 PANDEMIC ON THE REGENERATIVE MEDICINE MARKET

6.... REGENERATIVE MEDICINE MARKET, BY PRODUCT

6.1             INTRODUCTION
・       TABLE 11 FUNDING FOR REGENERATIVE MEDICINE PRODUCTS, 2019 (USD BILLION)
・       TABLE 12........ NUMBER OF CLINICAL TRIALS IN THE REGENERATIVE MEDICINE MARKET, 2018 VS. 2019
・       TABLE 13........... NEW PRODUCT APPROVALS IN THE REGENERATIVE MEDICINE MARKET, 2018-2020
・       TABLE 14.... REGENERATIVE MEDICINE MARKET: PRODUCT PIPELINE (2019)
・       TABLE 15............ REGENERATIVE MEDICINE MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
6.2             TISSUE-ENGINEERED PRODUCTS
6.2.1              RISING PREVALENCE OF CHRONIC WOUNDS TO DRIVE THE MARKET GROWTH
・       TABLE 16..... EXAMPLES OF COMMERCIALIZED TISSUE-ENGINEERED PRODUCTS
・       TABLE 17..... TISSUE-ENGINEERED PRODUCTS MARKET, BY REGION,
2018–2025 (USD MILLION)
・       TABLE 18.......... NORTH AMERICA: TISSUE-ENGINEERED PRODUCTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 19..... EUROPE: TISSUE-ENGINEERED PRODUCTS MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
・       TABLE 20......... APAC: TISSUE-ENGINEERED PRODUCTS MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
6.3             CELL THERAPIES
・       TABLE 21...... COMMERCIALIZED CELL THERAPIES AVAILABLE IN THE MARKET
・       TABLE 22....... CELL THERAPIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 23... CELL THERAPIES MARKET, BY REGION, 2018–2025 (USD MILLION)
・       TABLE 24. NORTH AMERICA: CELL THERAPIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
・       TABLE 25............ EUROPE: CELL THERAPIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
・       TABLE 26 APAC: CELL THERAPIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.3.1              AUTOLOGOUS THERAPIES
6.3.1.1            AUTOLOGOUS THERAPIES SEGMENT TO REGISTER THE HIGHEST GROWTH IN THE CELL THERAPIES MARKET
・       TABLE 27....... EXAMPLES OF COMMERCIALIZED AUTOLOGOUS CELL THERAPIES
・       TABLE 28..... AUTOLOGOUS THERAPIES MARKET, BY REGION, 2018–2025 (USD MILLION)
・       TABLE 29... NORTH AMERICA: AUTOLOGOUS THERAPIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
・       TABLE 30 EUROPE: AUTOLOGOUS THERAPIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
・       TABLE 31.... APAC: AUTOLOGOUS THERAPIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
6.3.2              ALLOGENEIC THERAPIES
6.3.2.1            RISING INCIDENCE OF CHRONIC CONDITIONS TO DRIVE THE MARKET GROWTH
・       TABLE 32......... EXAMPLES OF COMMERCIALIZED ALLOGENEIC CELL THERAPIES
・       TABLE 33 ALLOGENEIC THERAPIES MARKET, BY REGION, 2018–2025 (USD MILLION)
・       TABLE 34..... NORTH AMERICA: ALLOGENEIC THERAPIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
・       TABLE 35.. EUROPE: ALLOGENEIC THERAPIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
・       TABLE 36..... APAC: ALLOGENEIC THERAPIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
6.4             GENE THERAPIES
6.4.1              GROWING NUMBER OF CANCER CASES TO DRIVE MARKET GROWTH
・       TABLE 37.......... EXAMPLES OF COMMERCIALIZED GENE THERAPIES
・       TABLE 38.. GENE THERAPIES MARKET, BY REGION, 2018–2025 (USD MILLION)
・       TABLE 39 NORTH AMERICA: GENE THERAPIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
・       TABLE 40........... EUROPE: GENE THERAPIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
・       TABLE 41..... APAC: GENE THERAPIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.5             PROGENITOR & STEM CELL THERAPIES.. 66
6.5.1              GROWING PRODUCT PIPELINE TO SUPPORT THE GROWTH OF THIS SEGMENT
・       TABLE 42.... EXAMPLES OF COMMERCIALIZED PROGENITOR & STEM CELL THERAPIES
・       TABLE 43.......... PROGENITOR & STEM CELL THERAPIES MARKET, BY REGION,
2018–2025 (USD MILLION)
・       TABLE 44... NORTH AMERICA: PROGENITOR & STEM CELL THERAPIES MARKET,
BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 45. EUROPE: PROGENITOR & STEM CELL THERAPIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 46. APAC: PROGENITOR & STEM CELL THERAPIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)

7.... REGENERATIVE MEDICINE MARKET, BY APPLICATION

7.1             INTRODUCTION
・       TABLE 47........... NUMBER OF CLINICAL TRIALS FOR REGENERATIVE MEDICINE PRODUCTS,
BY APPLICATION, 2018 VS. 2019
・       TABLE 48....... REGENERATIVE MEDICINE MARKET, BY APPLICATION,
2018–2025 (USD MILLION)
7.2             MUSCULOSKELETAL DISORDERS
7.2.1              INCREASING PREVALENCE OF ORTHOPEDIC DISORDERS TO DRIVE THE GROWTH OF THIS APPLICATION SEGMENT
・       TABLE 49......................... REGENERATIVE MEDICINE MARKET FOR MUSCULOSKELETAL DISORDERS,
BY REGION, 2018–2025 (USD MILLION)
・       TABLE 50. NORTH AMERICA: REGENERATIVE MEDICINE MARKET FOR MUSCULOSKELETAL DISORDERS, BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 51............ EUROPE: REGENERATIVE MEDICINE MARKET FOR MUSCULOSKELETAL DISORDERS, BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 52................ APAC: REGENERATIVE MEDICINE MARKET FOR MUSCULOSKELETAL DISORDERS, BY COUNTRY, 2018–2025 (USD MILLION)

7.3             ONCOLOGY
7.3.1              INCREASING INCIDENCE OF CANCER TO SUPPORT MARKET GROWTH
・       TABLE 53.. NUMBER OF PATIENTS, BY TYPE OF CANCER, 2012–2030
・       TABLE 54 INDICATIVE LIST OF FEW COMMERCIALIZED REGENERATIVE CELL THERAPIES FOR THE TREATMENT OF CANCER
・       TABLE 55..... REGENERATIVE MEDICINE MARKET FOR ONCOLOGY, BY REGION,
2018–2025 (USD MILLION)
・       TABLE 56. NORTH AMERICA: REGENERATIVE MEDICINE MARKET FOR ONCOLOGY,
BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 57............ EUROPE: REGENERATIVE MEDICINE MARKET FOR ONCOLOGY, BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 58 APAC: REGENERATIVE MEDICINE MARKET FOR ONCOLOGY, BY COUNTRY, 2018–2025 (USD MILLION)
7.4             WOUND CARE
7.4.1              RISING PREVALENCE OF CHRONIC CONDITIONS TO DRIVE THE GROWTH OF THIS SEGMENT
・       TABLE 59.. REGENERATIVE MEDICINE PRODUCTS COMMERCIALIZED FOR THE TREATMENT OF ACUTE & CHRONIC WOUNDS
・       TABLE 60. REGENERATIVE MEDICINE MARKET FOR WOUND CARE, BY REGION,
2018–2025 (USD MILLION)
・       TABLE 61. NORTH AMERICA: REGENERATIVE MEDICINE MARKET FOR WOUND CARE,
BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 62. EUROPE: REGENERATIVE MEDICINE MARKET FOR WOUND CARE,
BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 63..... APAC: REGENERATIVE MEDICINE MARKET FOR WOUND CARE, BY COUNTRY, 2018–2025 (USD MILLION)
7.5             DENTAL
7.5.1              RISING INCIDENCE OF ORAL DISORDERS TO DRIVE THE MARKET GROWTH
・       TABLE 64.............. REGENERATIVE MEDICINE MARKET FOR DENTAL APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
・       TABLE 65. NORTH AMERICA: REGENERATIVE MEDICINE MARKET FOR DENTAL APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 66.. EUROPE: REGENERATIVE MEDICINE MARKET FOR DENTAL APPLICATIONS,
BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 67..... APAC: REGENERATIVE MEDICINE MARKET FOR DENTAL APPLICATIONS,
BY COUNTRY, 2018–2025 (USD MILLION)
7.6             OCULAR DISORDERS
7.6.1              RISING PRODUCT APPROVALS TO DRIVE MARKET GROWTH
・       TABLE 68............. REGENERATIVE MEDICINE MARKET FOR OCULAR DISORDERS, BY REGION, 2018–2025 (USD MILLION)
・       TABLE 69. NORTH AMERICA: REGENERATIVE MEDICINE MARKET FOR OCULAR DISORDERS, BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 70. EUROPE: REGENERATIVE MEDICINE MARKET FOR OCULAR DISORDERS,
BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 71..... APAC: REGENERATIVE MEDICINE MARKET FOR OCULAR DISORDERS,
BY COUNTRY, 2018–2025 (USD MILLION)

7.7             OTHER APPLICATIONS
・       TABLE 72............... REGENERATIVE MEDICINE MARKET FOR OTHER APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
・       TABLE 73. NORTH AMERICA: REGENERATIVE MEDICINE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 74... EUROPE: REGENERATIVE MEDICINE MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 75....... APAC: REGENERATIVE MEDICINE MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2018–2025 (USD MILLION)

8.... REGENERATIVE MEDICINE MARKET, BY REGION

8.1             INTRODUCTION
・       TABLE 76..... NUMBER OF PLAYERS IN THE REGENERATIVE MEDICINE MARKET,
BY REGION, 2018 VS. 2019
・       TABLE 77........... NUMBER OF CLINICAL TRIALS FOR REGENERATIVE MEDICINE, BY REGION (2019)
・       TABLE 78..... REGENERATIVE MEDICINE MARKET, BY REGION, 2018–2025 (USD MILLION)
8.2             NORTH AMERICA
・       FIGURE 16..... NORTH AMERICA: REGENERATIVE MEDICINE MARKET SNAPSHOT
・       TABLE 79... NORTH AMERICA: REGENERATIVE MEDICINE MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
・       TABLE 80... NORTH AMERICA: REGENERATIVE MEDICINE MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
・       TABLE 81....... NORTH AMERICA: CELL THERAPIES MARKET, BY TYPE,
2018–2025 (USD MILLION)
・       TABLE 82... NORTH AMERICA: REGENERATIVE MEDICINE MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.2.1              US
8.2.1.1            GROWING PRODUCT PIPELINE TO DRIVE THE MARKET IN THE US
・       TABLE 83..... PRODUCTS ANTICIPATED FOR APPROVALS IN THE US IN 2020
・       TABLE 84... PRODUCTS ANTICIPATED FOR FILINGS IN THE US IN 2020
・       TABLE 85...... US: REGENERATIVE MEDICINE MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
・       TABLE 86. US: CELL THERAPIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 87.. US: REGENERATIVE MEDICINE MARKET, BY APPLICATION,
2018–2025 (USD MILLION)
8.2.2              CANADA
8.2.2.1            INCREASING INVESTMENTS IN R&D TO DRIVE MARKET GROWTH
・       TABLE 88 CANADA: REGENERATIVE MEDICINE MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
・       TABLE 89. CANADA: CELL THERAPIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 90............. CANADA: REGENERATIVE MEDICINE MARKET, BY APPLICATION,
2018–2025 (USD MILLION)
8.3             EUROPE
・       TABLE 91............ EUROPE: RESEARCH FUNDING OVERVIEW (2017)
・       TABLE 92.... PRODUCTS ANTICIPATED FOR APPROVALS IN EUROPE IN 2020
・       TABLE 93. PRODUCTS ANTICIPATED FOR FILINGS IN EUROPE IN 2020
・       TABLE 94 EUROPE: REGENERATIVE MEDICINE MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
・       TABLE 95 EUROPE: REGENERATIVE MEDICINE MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
・       TABLE 96.. EUROPE: CELL THERAPIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 97.............. EUROPE: REGENERATIVE MEDICINE MARKET, BY APPLICATION,
2018–2025 (USD MILLION)
8.3.1              UK
8.3.1.1            RISING PREVALENCE OF CHRONIC CONDITIONS TO DRIVE MARKET GROWTH IN
THE UK
・       TABLE 98...... UK: REGENERATIVE MEDICINE MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
・       TABLE 99. UK: CELL THERAPIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 100 UK: REGENERATIVE MEDICINE MARKET, BY APPLICATION,
2018–2025 (USD MILLION)
8.3.2              GERMANY
8.3.2.1            RISING HEALTHCARE EXPENDITURE TO PROPEL MARKET GROWTH
・       TABLE 101.......... GERMANY: REGENERATIVE MEDICINE MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
・       TABLE 102..... GERMANY: CELL THERAPIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 103.......... GERMANY: REGENERATIVE MEDICINE MARKET, BY APPLICATION,
2018–2025 (USD MILLION)
8.3.3              FRANCE
8.3.3.1            RISING R&D EXPENDITURE, A MAJOR GROWTH DRIVER IN FRANCE
・       TABLE 104............ FRANCE: REGENERATIVE MEDICINE MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
・       TABLE 105 FRANCE: CELL THERAPIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 106............ FRANCE: REGENERATIVE MEDICINE MARKET, BY APPLICATION,
2018–2025 (USD MILLION)
8.3.4              REST OF EUROPE
・       TABLE 107... ROE: REGENERATIVE MEDICINE MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
・       TABLE 108..... ROE: CELL THERAPIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 109................. ROE: REGENERATIVE MEDICINE MARKET, BY APPLICATION,
2018–2025 (USD MILLION)
8.4             ASIA PACIFIC
・       FIGURE 17.......... ASIA PACIFIC: REGENERATIVE MEDICINE MARKET SNAPSHOT
・       TABLE 110.. APAC: REGENERATIVE MEDICINE MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
・       TABLE 111. APAC: REGENERATIVE MEDICINE MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
・       TABLE 112.... APAC: CELL THERAPIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 113................ APAC: REGENERATIVE MEDICINE MARKET, BY APPLICATION,
2018–2025 (USD MILLION)

8.4.1              JAPAN
8.4.1.1            COMPARATIVELY LENIENT REGULATIONS AND RISING GERIATRIC POPULATION TO DRIVE MARKET GROWTH
・       TABLE 114 JAPAN: REGENERATIVE MEDICINE MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
・       TABLE 115.. JAPAN: CELL THERAPIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 116.............. JAPAN: REGENERATIVE MEDICINE MARKET, BY APPLICATION,
2018–2025 (USD MILLION)
8.4.2              CHINA
8.4.2.1            FAVORABLE INVESTMENTS AND GOVERNMENT SUPPORT TO DRIVE MARKET GROWTH IN CHINA
・       TABLE 117 CHINA: REGENERATIVE MEDICINE MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
・       TABLE 118.. CHINA: CELL THERAPIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 119.............. CHINA: REGENERATIVE MEDICINE MARKET, BY APPLICATION,
2018–2025 (USD MILLION)
8.4.3              AUSTRALIA
8.4.3.1            STRONG RESEARCH BASE AND AVAILABILITY OF FUNDS TO DRIVE MARKET GROWTH
・       TABLE 120........ AUSTRALIA: REGENERATIVE MEDICINE MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
・       TABLE 121.... AUSTRALIA: CELL THERAPIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 122........ AUSTRALIA: REGENERATIVE MEDICINE MARKET, BY APPLICATION,
2018–2025 (USD MILLION)
8.4.4              ROAPAC
・       TABLE 123............ ROAPAC: REGENERATIVE MEDICINE MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
・       TABLE 124 ROAPAC: CELL THERAPIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 125............ ROAPAC: REGENERATIVE MEDICINE MARKET, BY APPLICATION,
2018–2025 (USD MILLION)
8.5             REST OF THE WORLD
・       TABLE 126.. ROW: REGENERATIVE MEDICINE MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
・       TABLE 127................ ROW: REGENERATIVE MEDICINE MARKET, BY APPLICATION,
2018–2025 (USD MILLION)

9.... COMPETITIVE LANDSCAPE

9.1             OVERVIEW
・       FIGURE 18.... KEY DEVELOPMENTS IN THE REGENERATIVE MEDICINE MARKET (JANUARY 2017 –AUGUST 2020)
9.2             CELL THERAPY MARKET SHARE ANALYSIS
・       FIGURE 19 CELL THERAPY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019
9.3             GENE THERAPY MARKET SHARE ANALYSIS
・       FIGURE 20.......... GENE THERAPY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019
9.4             TISSUE ENGINEERING MARKET RANKING
・       FIGURE 21............. TISSUE ENGINEERING MARKET RANKING, 2019
9.5             COMPETITIVE SCENARIO
9.5.1              PRODUCT LAUNCHES & REGULATORY APPROVALS
・       TABLE 128......... PRODUCT LAUNCHES & REGULATORY APPROVALS
(JANUARY 2017–AUGUST 2020)
9.5.2              COLLABORATIONS
・       TABLE 129........ COLLABORATIONS (JANUARY 2017–AUGUST 2020)
9.5.3              ACQUISITIONS
・       TABLE 130............. ACQUISITIONS (JANUARY 2017–AUGUST 2020)
9.5.4              EXPANSIONS
・       TABLE 131............... EXPANSIONS (JANUARY 2017–AUGUST 2020)

10.. COMPANY EVALUATION MATRIX AND COMPANY PROFILES

10.1          COMPANY EVALUATION MATRIX DEFINITION AND METHODOLOGY
10.1.1            VENDOR INCLUSION CRITERIA
10.1.2            STARS
10.1.3            EMERGING LEADERS.. 119
10.1.4            PERVASIVE
10.1.5            PARTICIPANTS
・       FIGURE 22.......... REGENERATIVE MEDICINE MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019
10.2          COMPANY EVALUATION MATRIX FOR START-UPS (2019)
10.2.1            PROGRESSIVE COMPANIES
10.2.2            RESPONSIVE COMPANIES
10.2.3            STARTING BLOCKS.. 121
10.2.4            DYNAMIC COMPANIES.. 121
・       FIGURE 23.......... REGENERATIVE MEDICINE MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS, 2019
10.3          COMPANY PROFILES
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW)*
10.3.1            SMITH & NEPHEW PLC
・       FIGURE 24...... SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2019)
10.3.2            VERICEL CORPORATION
・       FIGURE 25.... VERICEL CORPORATION: COMPANY SNAPSHOT (2019)
10.3.3            INTEGRA LIFESCIENCES HOLDINGS CORPORATION
・       FIGURE 26........ INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT (2019)
10.3.4            MIMEDX GROUP
・       FIGURE 27............. MIMEDX GROUP: COMPANY SNAPSHOT (2019)
10.3.5            NOVARTIS AG
・       FIGURE 28..................... NOVARTIS: COMPANY SNAPSHOT (2019)
10.3.6            STRYKER CORPORATION
・       FIGURE 29... STRYKER CORPORATION: COMPANY SNAPSHOT (2019)
10.3.7            ORGANOGENESIS INC.
・       FIGURE 30........... ORGANOGENESIS: COMPANY SNAPSHOT (2019)
10.3.8            MEDIPOST CO., LTD.
・       FIGURE 31........ MEDIPOST CO., LTD.: COMPANY SNAPSHOT (2019)
10.3.9            3M GROUP
・       FIGURE 32.................... 3M GROUP: COMPANY SNAPSHOT (2019)
10.3.10         MISONIX
・       FIGURE 33....................... MISONIX: COMPANY SNAPSHOT (2019)
10.3.11         ZIMMER BIOMET
・       FIGURE 34............. ZIMMER BIOMET: COMPANY SNAPSHOT (2019)
10.3.12         MEDTRONIC PLC
・       FIGURE 35............. MEDTRONIC PLC: COMPANY SNAPSHOT (2019)
10.3.13         AMGEN, INC.
・       FIGURE 36.................. AMGEN, INC.: COMPANY SNAPSHOT (2019)
10.3.14         ALLERGAN
・       FIGURE 37..................... ALLERGAN: COMPANY SNAPSHOT (2019)
10.3.15         TAKEDA PHARMACEUTICAL COMPANY LIMITED
・       FIGURE 38 TAKEDA PHARMACEUTICAL COMPANY LIMITED: COMPANY SNAPSHOT (2019)
10.3.16         ORTHOCELL LTD.
10.3.17         TEGO SCIENCE, INC.
10.3.18         CORESTEM, INC.
10.3.19         ANTEROGEN CO., LTD.
10.3.20         BLUEBIRD BIO
10.3.21         SPARK THERAPEUTICS
10.3.22         KITE PHARMA
10.3.23         APAC BIOTECH
10.3.24         SHENZHEN SIBIONO GENETECH CO., LTD.
10.3.25         ASPECT BIOSYSTEMS
*BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
11.. APPENDIX

当レポートのプレスリリースは発行されておりません。